The Delta variant was first identified in the United States in April and by May it was well onto its exponential growth curve, doubling every 10-12 days, as the basis for Covid infections, now reaching over 96% prevalence. Ironically, on 1 May, the CDC announced it would stop monitoring post-vaccination breakthrough infections unless they led to hospitalizations or deaths. This decision can be seen as exceptionally ill-advised and has led to a country flying blind in its attempt to confront its fourth wave of infections – one that has rapidly led to well over 100,000 new cases per day and more than 60,000 hospitalizations, both higher than the US first and second pandemic waves. It is unfathomable that we do not know how many of these are occurring in people who were vaccinated.
Most people who get Covid infections after being fully vaccinated have mild to moderate symptoms, and generally have been thought to avoid hospitalizations. But that sense of confidence about vaccine protection was built upon the pre-Delta data when the CDC was monitoring breakthroughs. Still being reported by CDC, from their latest website data, and a constant refrain from public health officials, is that “99.99% of people fully vaccinated against Covid-19 have not had a breakthrough case resulting in hospitalization or death.” That could not be further from the truth. In the July Provincetown Delta outbreaks that the CDC reported on the risk of fully vaccinated requiring hospitalization was 1%, not .01%, and that may not be a reliable estimate for the incidence of such infections occurring throughout the country.
Why is this so critically important? For one, the false sense of security transmitted by CDC’s lack of data in the Delta wave likely fosters complacency and lack of protective measures such as masks and distancing. The mission of the CDC to prevent such illness, and the first step is to collect the relevant data. It would be very simple to know the vaccination status of every American with a breakthrough infection admitted to the hospital with Covid-19, along with key demographics such as age, time from vaccination, which vaccine, and co-existing medical conditions. The PCR diagnostic test for each patient has an accompanying cycle threshold (Ct) value, which is an indicator of viral load, and would be important to track. Moreover, the sample of the virus could undergo genomic sequencing to determine whether there has been further evolution of the virus and blood samples for neutralizing antibody levels that could be obtained in as many patients as possible. Contact tracing of these individuals would help determine the true rate of transmission from other vaccines, something that is pure conjecture. Such systematic collection of data would be the foundation for understanding who is at risk for breakthrough infections, determining the current level of effectiveness of vaccines and whether, when, and in whom, booster shots should be recommended. It is remarkable that none of this is getting done for hospitalized patients, who represent an undetermined fraction of the people who are getting quite ill, some requiring monoclonal antibody infusions to pre-empt getting admitted.
This is not by any means the first breakdown of the CDC in managing and communicating about the pandemic. But with billions of dollars allocated to CDC earlier this year for improved Covid-19 surveillance, this represents a blatant failure that is putting millions of vaccinated Americans at unnecessary risk for breakthrough infections and leaving us without a navigational system for the US Delta wave.

News
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]
AI matches doctors in mapping lung tumors for radiation therapy
In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy tissue. But this process, called [...]
Scientists Finally “See” Key Protein That Controls Inflammation
Researchers used advanced microscopy to uncover important protein structures. For the first time, two important protein structures in the human body are being visualized, thanks in part to cutting-edge technology at the University of [...]
AI tool detects 9 types of dementia from a single brain scan
Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single, widely available scan—a transformative [...]
Is plastic packaging putting more than just food on your plate?
New research reveals that common food packaging and utensils can shed microscopic plastics into our food, prompting urgent calls for stricter testing and updated regulations to protect public health. Beyond microplastics: The analysis intentionally [...]
Aging Spreads Through the Bloodstream
Summary: New research reveals that aging isn’t just a local cellular process—it can spread throughout the body via the bloodstream. A redox-sensitive protein called ReHMGB1, secreted by senescent cells, was found to trigger aging features [...]
AI and nanomedicine find rare biomarkers for prostrate cancer and atherosclerosis
Imagine a stadium packed with 75,000 fans, all wearing green and white jerseys—except one person in a solid green shirt. Finding that person would be tough. That's how hard it is for scientists to [...]
Are Pesticides Breeding the Next Pandemic? Experts Warn of Fungal Superbugs
Fungicides used in agriculture have been linked to an increase in resistance to antifungal drugs in both humans and animals. Fungal infections are on the rise, and two UC Davis infectious disease experts, Dr. George Thompson [...]
Scientists Crack the 500-Million-Year-Old Code That Controls Your Immune System
A collaborative team from Penn Medicine and Penn Engineering has uncovered the mathematical principles behind a 500-million-year-old protein network that determines whether foreign materials are recognized as friend or foe. How does your body [...]
Team discovers how tiny parts of cells stay organized, new insights for blocking cancer growth
A team of international researchers led by scientists at City of Hope provides the most thorough account yet of an elusive target for cancer treatment. Published in Science Advances, the study suggests a complex signaling [...]
Nanomaterials in Ophthalmology: A Review
Eye diseases are becoming more common. In 2020, over 250 million people had mild vision problems, and 295 million experienced moderate to severe ocular conditions. In response, researchers are turning to nanotechnology and nanomaterials—tools that are transforming [...]
Natural Plant Extract Removes up to 90% of Microplastics From Water
Researchers found that natural polymers derived from okra and fenugreek are highly effective at removing microplastics from water. The same sticky substances that make okra slimy and give fenugreek its gel-like texture could help [...]
Instant coffee may damage your eyes, genetic study finds
A new genetic study shows that just one extra cup of instant coffee a day could significantly increase your risk of developing dry AMD, shedding fresh light on how our daily beverage choices may [...]
Nanoneedle patch offers painless alternative to traditional cancer biopsies
A patch containing tens of millions of microscopic nanoneedles could soon replace traditional biopsies, scientists have found. The patch offers a painless and less invasive alternative for millions of patients worldwide who undergo biopsies [...]
Small antibodies provide broad protection against SARS coronaviruses
Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous early and recent SARS-CoV-2 variants. The unique antibodies target an [...]
Controlling This One Molecule Could Halt Alzheimer’s in Its Tracks
New research identifies the immune molecule STING as a driver of brain damage in Alzheimer’s. A new approach to Alzheimer’s disease has led to an exciting discovery that could help stop the devastating cognitive decline [...]